- Home
- ANIX vs SGMO Comparison
ANIX vs SGMO Comparison
Compare ANIX & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- SGMO
- Stock Information
- Founded
- ANIX 1982
- SGMO 1995
- Country
- ANIX United States
- SGMO United States
- Employees
- ANIX N/A
- SGMO N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANIX Health Care
- SGMO Health Care
- Exchange
- ANIX Nasdaq
- SGMO Nasdaq
- Market Cap
- ANIX 108.9M
- SGMO 122.8M
- IPO Year
- ANIX 1987
- SGMO 2000
- Fundamental
- Price
- ANIX $3.15
- SGMO $0.53
- Analyst Decision
- ANIX Strong Buy
- SGMO Buy
- Analyst Count
- ANIX 3
- SGMO 6
- Target Price
- ANIX $9.00
- SGMO $4.50
- AVG Volume (30 Days)
- ANIX 156.0K
- SGMO 5.6M
- Earning Date
- ANIX 09-05-2025
- SGMO 08-05-2025
- Dividend Yield
- ANIX N/A
- SGMO N/A
- EPS Growth
- ANIX N/A
- SGMO N/A
- EPS
- ANIX N/A
- SGMO N/A
- Revenue
- ANIX N/A
- SGMO $63,756,000.00
- Revenue This Year
- ANIX N/A
- SGMO N/A
- Revenue Next Year
- ANIX N/A
- SGMO N/A
- P/E Ratio
- ANIX N/A
- SGMO N/A
- Revenue Growth
- ANIX N/A
- SGMO 239.92
- 52 Week Low
- ANIX $2.07
- SGMO $0.32
- 52 Week High
- ANIX $4.20
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- ANIX 48.71
- SGMO 50.13
- Support Level
- ANIX $3.18
- SGMO $0.50
- Resistance Level
- ANIX $3.39
- SGMO $0.55
- Average True Range (ATR)
- ANIX 0.19
- SGMO 0.05
- MACD
- ANIX -0.05
- SGMO 0.00
- Stochastic Oscillator
- ANIX 4.41
- SGMO 57.90
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.